Lasofoxifene in Postmenopausal Women with OsteoporosisSteven R. Cummings, Richard Eastell, Slobodan Vukičević et al.|New England Journal of Medicine|2010Cited by 388
Benefits of eculizumab in AQP4+ neuromyelitis optica spectrum disorder: Subgroup analyses of the randomized controlled phase 3 PREVENT trialJacqueline Palace, Carolina Mainella, Dean M. Wingerchuk et al.|Multiple Sclerosis and Related Disorders|2020Cited by 41